Your browser doesn't support javascript.
loading
Approach for in vivo delivery of CRISPR/Cas system: a recent update and future prospect.
Chuang, Yu-Fan; Phipps, Andrew J; Lin, Fan-Li; Hecht, Valerie; Hewitt, Alex W; Wang, Peng-Yuan; Liu, Guei-Sheung.
Affiliation
  • Chuang YF; Shenzhen Key Laboratory of Biomimetic Materials and Cellular Immunomodulation, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, 1068 Xueyuan Avenue, Shenzhen University Town, Shenzhen, 518055, China.
  • Phipps AJ; Menzies Institute for Medical Research, University of Tasmania, 17 Liverpool Street, Hobart, TAS, 7000, Australia.
  • Lin FL; Wicking Dementia Research and Education Centre, College of Health and Medicine, University of Tasmania, Hobart, TAS, Australia.
  • Hecht V; Shenzhen Key Laboratory of Biomimetic Materials and Cellular Immunomodulation, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, 1068 Xueyuan Avenue, Shenzhen University Town, Shenzhen, 518055, China.
  • Hewitt AW; Menzies Institute for Medical Research, University of Tasmania, 17 Liverpool Street, Hobart, TAS, 7000, Australia.
  • Wang PY; School of Natural Sciences, University of Tasmania, Hobart, TAS, Australia.
  • Liu GS; Menzies Institute for Medical Research, University of Tasmania, 17 Liverpool Street, Hobart, TAS, 7000, Australia.
Cell Mol Life Sci ; 78(6): 2683-2708, 2021 Mar.
Article in En | MEDLINE | ID: mdl-33388855

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: CRISPR-Cas Systems / Gene Editing Limits: Animals / Humans Language: En Journal: Cell Mol Life Sci Journal subject: BIOLOGIA MOLECULAR Year: 2021 Type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: CRISPR-Cas Systems / Gene Editing Limits: Animals / Humans Language: En Journal: Cell Mol Life Sci Journal subject: BIOLOGIA MOLECULAR Year: 2021 Type: Article Affiliation country: China